Zobrazeno 1 - 10
of 140
pro vyhledávání: '"Demoré Béatrice"'
Publikováno v:
Pharmaceutical Technology in Hospital Pharmacy, Vol 8, Iss 1, Pp 260-6 (2023)
To the best of our knowledge, few studies have been published on the stability of cabazitaxel in infusion bags. Stabilis® database has selected a study demonstrating the stability of this molecule at 0.15 mg/mL for 28 days at 4 °C and 25 °C in pol
Externí odkaz:
https://doaj.org/article/0865f3375fdd4735b7049b7df50174d8
Publikováno v:
Pharmaceutical Technology in Hospital Pharmacy, Vol 8, Iss 1, Pp 20235-8 (2023)
The measurement of osmolality is used by many authors as an additional stability criterion of a drug in solution. In the current state of knowledge, no scientific publication correlates the osmolality values and the stability of a solution. To study
Externí odkaz:
https://doaj.org/article/91d25813a5ad400486586791f1d4e7d0
Publikováno v:
Pharmaceutical Technology in Hospital Pharmacy, Vol 7, Iss 1, Pp 11-6 (2022)
Azacitidine is a pyrimidine nucleoside analogue whose stability is temperature dependent. Numerous publications have studied the stability of this drug with discordant results. The purpose of this work is to study the stability of azacitidine suspens
Externí odkaz:
https://doaj.org/article/c5eacfdbe5cc4b538a5ff9973c84b59f
Publikováno v:
Pharmaceutical Technology in Hospital Pharmacy, Vol 7, Iss 1, Pp 221-31 (2022)
Patients hospitalized in intensive care units often require multiple drug infusions. Due to limited intravenous accesses, concomitant administration of drugs in the same infusion line is often necessary. Compatibility studies of Y-site administration
Externí odkaz:
https://doaj.org/article/bd6bd9b8229040818c64c0d5929775f2
Autor:
Polo Caroline, D’Huart Elise, Lesperlette Gwendoline, Vigneron Jean, Meyer Florence, Demoré Béatrice
Publikováno v:
Pharmaceutical Technology in Hospital Pharmacy, Vol 5, Iss 1, Pp 114-23 (2020)
Concomitant administration of two incompatible drugs in the same infusion line can lead to a precipitation which could have clinical consequences for patients. The objective of this work was to study the physical compatibility of injectable posaconaz
Externí odkaz:
https://doaj.org/article/422592d1c0ac45d789108a08cb5e5773
Publikováno v:
Pharmaceutical Technology in Hospital Pharmacy, Vol 4, Iss 2, Pp 59-67 (2019)
Cefotaxime sodium is an antibiotic used to treat severe infections such as in intensive care units (ICUs). The recommended dose of cefotaxime sodium can vary from 3 grams (g) to 24 g per day and publications have demonstrated that continuous administ
Externí odkaz:
https://doaj.org/article/2abd5e1a5d9846eb9e6af07af940a7de
Publikováno v:
Pharmaceutical Technology in Hospital Pharmacy, Vol 4, Iss 1, Pp 29-40 (2019)
The objectives were to perform an observation of the administration of injectable drugs in three ICUs, to identify injectable drugs administered by Y-site infusion or mixed in the same container, to compare with physical compatibility data available
Externí odkaz:
https://doaj.org/article/17bbddba865b40c0b781d5aba96d1bea
Publikováno v:
Pharmaceutical Technology in Hospital Pharmacy, Vol 3, Iss 4, Pp 227-234 (2018)
Our department of pharmacy takes over all the medical skin tests prescribed by the allergy department. The production takes place in specific premises, with qualified and calibrated equipment, by a qualified and regularly assessed staff—in complian
Externí odkaz:
https://doaj.org/article/2df2d5624a064a5d8a75650957ca9309
Autor:
D’Huart Elise, Vigneron Jean, Ranchon Florence, Vantard Nicolas, Rioufol Catherine, Demoré Béatrice
Publikováno v:
Pharmaceutical Technology in Hospital Pharmacy, Vol 3, Iss 3, Pp 135-142 (2018)
Many publications described sodium thiosulfate used to prevent the renal toxicity induced by cisplatin hyperthermic intraperitoneal chemotherapy. After around 60 or 90 minutes of hyperthermic chemotherapy, cisplatin was drained and then, sodium thios
Externí odkaz:
https://doaj.org/article/7995afcc18614fc6887bce6997c02108
Publikováno v:
Pharmaceutical Technology in Hospital Pharmacy, Vol 3, Iss 1, Pp 13-21 (2018)
Bendamustine is used for the treatment of non-Hodgkin lymphoma, chronic lymphocytic leukaemia and myeloma. The stability of bendamustine is highly dependent on temperature and chloride-ion concentration. Limited stability data are available. The obje
Externí odkaz:
https://doaj.org/article/bf1d6438941448c8b34c1ab2c6f6a0e0